About

SyntexBioMed, established in 2024, was founded with a clear vision:

to revolutionize the diagnostic industry by providing accessible, reliable, and accurate in vitro diagnostic solutions. Our mission is rooted in advancing healthcare by enabling early detection, efficient diagnosis, and improved patient outcomes.

​​

Looking ahead, SyntexBioMed aims to lead the global healthcare market with innovative products that meet the highest international standards.

We are committed to pushing the boundaries of diagnostic technology and partnering with medical institutions, research organizations, and distributors to broaden our impact.

​​

As we expand from the United States to the international stage, our wish is to be recognized as a trusted name in diagnostics—an enduring company that enhances the quality of care worldwide through sustainable and cutting-edge solutions.